A. Spagnoletti

460 total citations
13 papers, 82 citations indexed

About

A. Spagnoletti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, A. Spagnoletti has authored 13 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in A. Spagnoletti's work include Colorectal Cancer Treatments and Studies (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). A. Spagnoletti is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). A. Spagnoletti collaborates with scholars based in Italy, Spain and Sweden. A. Spagnoletti's co-authors include Filippo de Braud, Margherita Ambrosini, Massimo Di Nicola, Giovanni Fucà, Marco Platania, Alberto Zaniboni, Giovanni Apolone, Riccardo Lobefaro, Cinzia Brunelli and Arsela Prelaj and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

A. Spagnoletti

12 papers receiving 81 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Spagnoletti Italy	4	56	22	18	14	9	13	82
Beatriz Núñez Spain	6	36 0.6×	9 0.4×	13 0.7×	24 1.7×	12 1.3×	11	81
Anushka De Costa United States	4	55 1.0×	30 1.4×	16 0.9×	10 0.7×	13 1.4×	7	69
Ting Ying Ng China	5	37 0.7×	5 0.2×	9 0.5×	9 0.6×	11 1.2×	5	55
Judith Sirokay Germany	4	37 0.7×	19 0.9×	7 0.4×	5 0.4×	9 1.0×	6	57
Eva Sum Germany	3	34 0.6×	24 1.1×	9 0.5×	8 0.6×	11 1.2×	7	59
Jaseela Chiramel United Kingdom	4	55 1.0×	6 0.3×	7 0.4×	28 2.0×	12 1.3×	6	76
C. Lafond France	4	45 0.8×	12 0.5×	4 0.2×	21 1.5×	6 0.7×	6	63
Nurgul Kilavuz United States	4	49 0.9×	18 0.8×	13 0.7×	9 0.6×	4 0.4×	7	59
Samuel M. Rubinstein United States	5	42 0.8×	11 0.5×	6 0.3×	13 0.9×	16 1.8×	10	68
Anne-Laure Breton France	4	63 1.1×	10 0.5×	8 0.4×	9 0.6×	14 1.6×	5	83

Countries citing papers authored by A. Spagnoletti

Since Specialization

Citations

This map shows the geographic impact of A. Spagnoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Spagnoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Spagnoletti more than expected).

Fields of papers citing papers by A. Spagnoletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Spagnoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Spagnoletti. The network helps show where A. Spagnoletti may publish in the future.

Co-authorship network of co-authors of A. Spagnoletti

This figure shows the co-authorship network connecting the top 25 collaborators of A. Spagnoletti. A scholar is included among the top collaborators of A. Spagnoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Spagnoletti. A. Spagnoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Rossi, Ernesto, Lorenza Di Guardo, Ester Simeone, et al.. (2025). Tebentafusp in metastatic uveal melanoma patients: Results of the Italian expanded access program.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations

Pellat, Anna, Thomas Grinda, Arsela Prelaj, et al.. (2024). Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours. SHILAP Revista de lepidopterología. 6. 100091–100091. 1 indexed citations

Pellat, Anna, Thomas Grinda, Arsela Prelaj, et al.. (2023). 1689O Comprehensive mapping review of real-world evidence publications focusing on targeted therapies in solid tumors: A collaborative work from ESMO real-world data and Digital Health Working Group. Annals of Oncology. 34. S925–S925. 5 indexed citations

Fanotto, V., Daniele Rossini, Mariaelena Casagrande, et al.. (2023). Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies. Cancers. 15(22). 5451–5451. 1 indexed citations

Provenzano, Leonardo, M. A. Favali, Laura Mazzeo, et al.. (2023). 178P Explainable radiomics, machine and deep learning models to predict immune-checkpoint inhibitor treatment efficacy in advanced non-small cell lung cancer patients. Annals of Oncology. 34. S252–S252. 1 indexed citations

Borelli, Beatrice, Stefania Crucitta, Alessandra Boccaccino, et al.. (2023). TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients. Tumori Journal. 109(5). 481–489. 1 indexed citations

Dell’Aquila, Emanuela, Daniele Rossini, Marco Stellato, et al.. (2022). Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO. Clinical Colorectal Cancer. 21(3). 220–228. 6 indexed citations

Lobefaro, Riccardo, Luca Porcu, Cinzia Brunelli, et al.. (2022). Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors. ESMO Open. 7(2). 100457–100457. 20 indexed citations

Dell’Aquila, Emanuela, Daniele Rossini, Claudia Angela Maria Fulgenzi, et al.. (2022). Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials. ESMO Open. 7(6). 100606–100606. 3 indexed citations

10.

Spagnoletti, A., Marco Platania, Marta Brambilla, et al.. (2022). Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease. Tumori Journal. 108(6). 609–614. 3 indexed citations

11.

Provenzano, Leonardo, Valeria Cuccarini, Marco Platania, et al.. (2021). Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma. Tumori Journal. 107(6). NP136–NP140. 1 indexed citations

12.

Fucà, Giovanni, A. Spagnoletti, Margherita Ambrosini, Filippo de Braud, & Massimo Di Nicola. (2021). Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy. ESMO Open. 6(1). 100046–100046. 39 indexed citations

13.

Grassi, Massimiliano, A. Spagnoletti, & Alberto Puccini. (2020). Metastatic sarcoma: tailored strategies for a heterogeneous disease. memo - Magazine of European Medical Oncology. 13(2). 179–184.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact